C WorldWide Group Holding A S Has $12.20 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

C WorldWide Group Holding A S cut its position in The Cooper Companies, Inc. (NASDAQ:COO) by 75.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 132,704 shares of the medical device company’s stock after selling 410,073 shares during the quarter. C WorldWide Group Holding A S’s holdings in Cooper Companies were worth $12,199,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares during the last quarter. International Assets Investment Management LLC bought a new position in shares of Cooper Companies in the third quarter worth about $46,727,000. Swedbank AB raised its stake in shares of Cooper Companies by 14.0% in the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock worth $149,809,000 after acquiring an additional 200,000 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after acquiring an additional 194,118 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the subject of a number of recent research reports. Citigroup dropped their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley dropped their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Stock Down 0.2 %

Shares of NASDAQ:COO opened at $88.48 on Monday. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $17.66 billion, a PE ratio of 45.37, a PEG ratio of 2.25 and a beta of 1.00. The company has a 50 day moving average price of $92.94 and a two-hundred day moving average price of $99.66.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm earned $0.87 earnings per share. The business’s quarterly revenue was up 9.8% on a year-over-year basis. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.